• Mashup Score: 1

    Objective Cognitive impairment is common in patients with SLE but the cause is unknown. The current cross-sectional study examined the association between select SLE-related autoantibodies, other serological biomarkers and extensive blood–brain barrier (BBB) leakage in patients with SLE with and without cognitive impairment. In addition, we determined whether the relationship between SLE…

    Tweet Tweets with this article
    • #immunology #inflammation Dr. Hanly showed #SLE related #autoantibodies have been proposed to cause #cognitiveimpairment; however, were not associated with #cognitive #impairment even in the presence of extensive BBB leakage #Lupus https://t.co/atEIs5hDfP

  • Mashup Score: 1

    Objective Cognitive impairment is common in patients with SLE but the cause is unknown. The current cross-sectional study examined the association between select SLE-related autoantibodies, other serological biomarkers and extensive blood–brain barrier (BBB) leakage in patients with SLE with and without cognitive impairment. In addition, we determined whether the relationship between SLE…

    Tweet Tweets with this article
    • #immunology #inflammation Dr. Hanly showed #SLE related #autoantibodies have been proposed to cause #cognitiveimpairment; however, were not associated with #cognitive #impairment even in the presence of extensive BBB leakage #Lupus https://t.co/atEIs5hDfP

  • Mashup Score: 0

    Objective Cognitive impairment is common in patients with SLE but the cause is unknown. The current cross-sectional study examined the association between select SLE-related autoantibodies, other serological biomarkers and extensive blood–brain barrier (BBB) leakage in patients with SLE with and without cognitive impairment. In addition, we determined whether the relationship between SLE…

    Tweet Tweets with this article
    • #immunology #inflammation Dr. Hanly showed #SLE related #autoantibodies have been proposed to cause #cognitiveimpairment; however, were not associated with #cognitive #impairment even in the presence of extensive BBB leakage #Lupus https://t.co/atEIs5hDfP

  • Mashup Score: 0

    Whether a patient receives therapies controlling hyperinflammation in the acute stage of COVID may influence whether a patient experiences long COVID, say authors.

    Tweet Tweets with this article
    • Scientists who made a deep molecular dive into COVID-19 patients found that the presence of #autoantibodies in peripheral blood at the initial diagnosis was the first of 4 risk factors predicting if a patient would experience long COVID. https://t.co/N5ycE2ZM75 https://t.co/nwNhbHdpli